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Abstract
Acute kidney injury (AKI) is associated with increased rates of mortality. For unknown reasons, HIV infected individuals have
a higher risk of AKI than uninfected persons. We tested our hypothesis that increased circulating LPS increases renal
expression of HIV and that HIV transgenic (Tg26) mice have increased susceptibility to AKI. Tg26 mice harbor an HIV
transgene encoding all HIV genes except gag and pol, and develop a phenotype analogous to HIVAN. Mice were used at 4–6
weeks of age before the onset of gross renal disease. Mice were injected i.p. with LPS or sterile saline. Renal function, tubular
injury, cytokine expression, and HIV transcription were evaluated in Tg26 and wild type (WT) mice. LPS injection induced a
median 60.1-fold increase in HIV expression in spleen but no change in kidney. There was no significant difference in renal
function, cytokine expression, or tubular injury scores at baseline or 24 hours after LPS injection. HIV transcription was also
analyzed in vitro using a human renal tubular epithelial cell (RTEC) line. HIV transcription increased minimally in human
RTEC, by 1.47 fold, 48 hours after LPS exposure. We conclude that Tg26 mice do not increase HIV expression or have
increased susceptibility to LPS induced AKI. The increased risk of AKI in HIV infected patients is not mediated via increased
renal expression of HIV in the setting of sepsis. Moreover, renal regulation of HIV transcription is different to that in the
spleen.
Citation: Leventhal JS, Alsauskas Z, Snyder A, Gong P, Wang B, et al. (2011) Renal HIV Expression Is Unaffected by Serum LPS Levels in an HIV Transgenic Mouse
Model of LPS Induced Kidney Injury. PLoS ONE 6(6): e20688. doi:10.1371/journal.pone.0020688
Editor: Cheryl A. Stoddart, University of California, San Francisco, United States of America
Received January 19, 2011; Accepted May 6, 2011; Published June 16, 2011
Copyright:  2011 Leventhal et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases grant R01 DK078510 (to PI
MR) and by a National Kidney Foundation Fellowship Grant (to JL). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jeremy.leventhal@mssm.edu
Introduction
Recent data has identified HIV infected patients as a group
predisposed to acute kidney injury (AKI). A study by Wyatt et al.
analyzing billing codes for patients in New York state for the years
1995 and 2003, before and after the introduction of antiretroviral
therapy, revealed a risk for AKI in hospitalized HIV patients 2.82
times higher than their uninfected counterparts[1]. Furthermore,
HIV infected patients with AKI had a mortality risk 5.83 times
higher than patients without renal failure[1]. Importantly, as
opposed to the renal syndrome of HIV associated nephropathy
(HIVAN), black race was not an identified risk factor for AKI in
the HIV patients. An increased risk for AKI has also been ob-
served in both hospitalized and ambulatory HIV infected patient
populations[2,3]. This phenomenon is now well described in the
clinical literature yet lacks a mechanistic explanation.
Over half of the AKI events in an ambulatory HIV patient
population were related to infection[3]. Much research has been
conducted studying the effects of enteric bacterial translocation,
reflected in elevated serum lipopolysaccharide (LPS) levels, on
HIV progression and immune activation. In general, these studies
have found that higher circulating LPS levels are associated with
increased viral replication and a more advanced disease state[4];
Brenchley et al., 2006, Nat Med, 12, 1365–71}. The relationship
between serum LPS and the predisposition of HIV patients to AKI
has not been investigated.
Elevated serum LPS can be seen during bacterial sepsis, and
septic AKI can be modeled in animals by intraperitoneal injection
of LPS. LPS stimulates Toll-like receptor 4 (TLR4) of the innate
immune system. The resulting release of cytokines, mediated
through nuclear factor kappaB (NF-kB) activation[5], contributes
to AKI and is represented by increases in serum urea nitrogen
(SUN) and tubular injury [6].
First demonstrated in monocytes, NF-kB is also a necessary
transcription factor for HIV replication and its activation results in
HIV gene expression[7]. Subsequently, a relationship between
TLR4 activation and HIV transcription was demonstrated when
incubation of exposed human dermal microvessel endothelial cells
(HMEC) with LPS increased the activation of an HIV LTR
luciferase reporter construct[8]. Notably, this effect was abrogated
by cotransfection of dominant negative TLR4/NF-kB signaling
molecules[8], further supporting a role for LPS signaling through
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esized that LPS would also increase HIV transcription in renal
tubular epithelial cells (RTEC).
Whereas increased HIV transcription and plasma viral RNA is
recognized to occur in the setting of bacterial infection, research
on specific tissue transcriptional responses to LPS have been con-
flicting[9,10]. Several studies have found that the activating role of
LPS described in HMEC[8]. LPS incubation does not increase
HIV transcription in macrophages because of interferon-induced
suppression[11] that, conversely, decreases HIV replication. Ano-
ther study found that HIV transcription, measured with a pNL4-3-
luc reporter construct, failed to increase after stimulation with
LPS[12]. Notably, the experiment was conducted using trans-
fected HEK293T cells, a cell line originally derived from embryonic
kidney.
The effect of LPS on renal HIV transcription, and its sub-
sequent role in the pathogenesis of septic AKI has not been inves-
tigated. In this paper, we studied whether LPS induces increased
renal HIV transcription and if renal HIV expression leads to exag-
gerated inflammatory cytokine production, exacerbated tubular
injury and worsened renal function.
Methods
Ethics Statement
Biopsy tissue, from which the RT3 cell line was derived, was
collected at the time of diagnostic renal biopsy after written con-
sent was obtained under a protocol approved by the Mount Sinai
Institutional Review Board. All animal studies were performed
under a protocol (#07-1224) approved by the Mount Sinai Insti-
tutional Animal Care and Utilization Committee (IACUC) that
adheres to NIH guidelines of animal care.
HIV Transgenic Mice
The ‘‘Tg26’’ HIV-transgenic model of HIVAN has been exten-
sively characterized. [13–15] These mice harbor an HIV provirus
with deletions spanning the gag and pol genes that are expressed
under control of the endogenous HIV LTR promoter. Heterozy-
gous Tg26 mice develop disease closely mimicking the human
HIVAN phenotype several months after birth. We used four to six
week-old mice in these studies, an age at which Tg26 develop
proteinuria but not renal failure or histologic renal disease.
Animal Studies
Four to six week-old heterozygous Tg26 mice and/or wild-type
FVB/N (WT) littermates (controls) were weighed and adminis-
tered 20 mg/kg of Escherichia coli 0111:B4 standard preparation
LPS (Invivogen) or sterile saline by intraperitoneal (i.p.) injection.
Blood was drawn from mice immediately prior to injections and
immediately prior to sacrifice 24 hours later. Serum urea nitrogen
(SUN) concentrations were measured via photometric assay on a
Prochem V apparatus (Drew Scientific). At the time of sacrifice,
the right kidney was placed in 4% paraformaldehyde/PBS and
subsequently embedded in paraffin and the left was snap frozen in
liquid nitrogen and stored at 280 Celsius.
Quantitative real time PCR
Small slices (,100 mg) of snap frozen cortex from kidneys of
injected mice were homogenized in TRI REAGENT (Molecular
Research Center) with a handheld motorized pestle (Kontes).
RNA was isolated and quantified using a Nanodrop spectropho-
tometer (Thermo Scientific). 5 ug of total RNA was reverse tran-
scribed using SuperScript III First-Strand Synthesis System
(Invitrogen). cDNA was analyzed by quantitative real time PCR
(qPCR) at the Mount Sinai Quantitative PCR Shared Research
Facility on an ABI PRISM 7900HT Sequence Detection System
using the following parameters: 15 minutes at 94C, 1 minute at
58C, 1 minute at 72C for 40 cycles. Primers for amplification of
cyclophilin A (housekeeping control), MCP-1, TNF-a, CXCL5,
ICAM-1, IL-6, and IL-10 have been previously published [16–19].
Amplification of HIV tat/rev and tat/rev/nef transcripts was per-
formed with previously validated primer sets[20]. Primers for IFN-
a (forward) 59 GGTGGAGGTCATTGCAGAAT 39, (reverse) 59
ATGCCCAGCAGATCAAGAAG 39, IFN-b (forward) 59 CC-
CAGTGCTGGAGAAATTGT 39, (reverse) 59 CCCTATGGA-
GATGACGGAGA 39, murine Aquaporin 1 (forward) 59 AGG-
CTTCAATTACCCACTGGA 39, (reverse) 59 AGGCTTCAAT-
TACCCACTGGA 39, murine Cytokeratin 18 (forward) 59 CAG-
CCAGCGTCTATGCAGG 39, (reverese) 59 CTTTCTCGGT-
CTGGATTCCAC 39, murine E-cadherin (forward) 59 CAGG-
TCTCCTCATGGCTTTGC 39, (reverse) 59 CTTCCGAAAA-
GAAGGCTGTCC 39, murine Tamm-Horsfall (forward) 59 GA-
CCTGGATGCTGCTGGTAAT 39, (reverse) 59 GTGGCGT-
TGTTGTGGCATTC 39, murine von Willebrand’s Factor
(forward) 59 CTTCTGTACGCCTCAGCTATG 39, (reverse) 59
GCCGTTGTAATTCCCACACAAG 39, human Aquaporin 1
(forward) 59 TTAACCCTGCTCGGTCCTTTG 39, (reverse) 59
AGTCGTAGATGAGTACAGCCAG 39, human Cytokeratin 18
(forward) 59 ACAATGCCCGCATCGTTCT 39, (reverse) 59
GGATGTCGTTCTCCACAGACT 39, human E-cadherin (for-
ward) 59 CCCACCACGTACAAGGGTC 39, (reverse) 59 ATGC-
CATCGTTGTTCACTGGA 39, human Tamm-Horsfall (for-
ward) 59 CCGGCGGCTACTACGTCTA 39, (reverse) 59 TG-
CCATCTGCCATTATTCGATTT 39, and human von Will-
ebrand’s Factor (forward) 59 CCTGCCGCTCTCTCTCTTAC 39,
(reverse) 59 AGCACATGGTGTGATGGTCTG 39 were designed
using Primer Bank (http://pga.mgh.harvard.edu/primerbank/).
Statistics
Gene expression was calculated using the 2
(-DDCT) method
[21,22]. In short, 2
(-DCT) was calculated by first averaging the DCT
(CTTarget gene-CTControl gene) for replicates of each individual
sample and then calculating the mean of the averaged sample
DCT values. Changes in expression were calculated by dividing
the average DCT for each gene in an experimental group (LPS-
injected Tg26, WT, and saline-injected Tg26) by the DCT of the
control group (saline-injected WT). Changes in expression for an
individual animal were obtained similarly. Because the individual
fold change data was not distributed normally, differences in
median fold change were first compared using a Kruskal-Wallis
test. Subsequent pair-wise comparisons were performed with a
Mann-Whitney Test to detect significant differences between
individual groups.
Acute Tubular Necrosis (ATN) scores of H&E stained paraffin
embedded sections were similarly analyzed by first analyzing for
significant differences between both control and LPS injected
groups using a Kruskal-Wallis test. Pair-wise comparisons of
individual group ATN scores were performed using the Mann-
Whitney Test. Statistically significant differences were defined by
two-sided p,0.05.
Cell culture
RT3 cells, a human RTEC line, were grown from a human
biopsy sample collected in protocol approved by the Mount Sinai
Institutional Review Board, derived according to protocol as
previously described[23]. RT3 cells were conditionally immortal-
ized with pseudotyped lentivirus expressing temperature sensitive
large T-antigen as described previously [23]. Cells were grown in
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F12/DMEM with 1% fetal bovine serum (Invitrogen), 10 ng/ml
EGF (Sigma), 5 ug/ml transferrin (Sigma), 5 ug/ml insulin
(Sigma), 50 nmol/L selenium (MP Biomedical), 0.05 mmol/L
Hydrocortisone (Sigma), 5 pmol/L tri-iodothryronine (Sigma),
1 ng/ml Prostaglandin E1 MP Biomedical, 50 U/ml penicillin
and 50 ug/ml streptomycin [24,25].
To characterize RTEC cells, RNA was harvested using Trizol
(Molecular Research Center, Inc) per manufacturers directions
and expression of tubular epithelial markers Aquaporin-1, Cyto-
keratin 18, and Tamm-Horsfall protein compared to endothelial
cell von Willebrand’s Factor was analyzed by qPCR as described
above in ‘‘Quantitative real time PCR’’. For studies assessing the
response to LPS incubation, confluent cells were incubated in
media supplemented with 1 mg/ml of LPS for predetermined time
points. RNA was then harvested and analyzed for expression of
HIV using primers described above. All data presented was ob-
tained from four independent experiments.
HIV-1 Transduction
To optimize the efficiency of HIV transduction, we infected
RT3 cells with VSV-NL4-3:DG/P-EGFP, a lentiviral vector that
expresses the same parental gag/pol-deleted HIV provirus used to
create Tg26 mice. This vector also expresses enhanced green
fluorescent protein (EGFP) and is pseudotyped with the vesicular
stomatitis virus glycoprotein to broaden its tropism. We used this
virus to transduce human RTEC as described previously[19]. RT3
cells were incubated with viral supernatants for six hours and then
incubated in fresh media for an additional 96 hours before being
used in further experiments.
Renal histology
Immediately following sacrifice, the right kidney was stripped of
its capsule and immersion fixed in a 4% paraformaldehyde solu-
tion. Kidneys were paraffin-embedded, cut into 3 micron sagittal
sections, and stained with hematoxylin and eosin. The slides were
assigned an acute tubular necrosis (ATN) score by a blinded renal
pathologist (Vivette D’Agati, Columbia University). Each kidney
cross section was evaluated over its entire area under 20x and 40x
magnifications for histologic evidence of tubular single cell necro-
sis. The percentage of renal cortical area exhibiting tubular
epithelial necrosis was scored as follows: 0, none; 1, 10–25%; 2,
26–50%; 3.50%.
Results
HIV-transgenic mice are not predisposed to LPS-induced
AKI
To determine whether HIV-transgenic mice (Tg26) demon-
strate increased susceptibility to LPS-induced AKI, we injected
Tg26 mice and WT littermates with LPS. We used four to six
week-old mice, an age at which Tg26 mice in our colony do not
typically have histological renal disease or renal failure, to avoid
the confounding effect that preexisting chronic kidney disease
would have upon susceptibility to AKI.
There was no difference in the baseline serum urea nitrogen
(SUN) of Tg26 and WT mice (Figure 1A). Twenty-four hours after
LPS injection, SUN increased in both WT and Tg26 mice
(Figure 1B) with 19 of 24 Tg26 and 16 of 20 wild type mice
developing a 2-fold or greater increase in SUN. However, the
differences between the rise of SUN in both groups, 85.4 mg/dL
in Tg26 and 75.1 mg/dL in WT mice, was not statistically
significant (Figure 1C, p=0.41). Single cell tubular epithelial
necrosis was noted in all LPS injected samples (Figure 2A) and
acute tubular necrosis (ATN) scores were significantly higher in
LPS injected samples (Figure 2B). However, there was no
significant difference in the ATN scores between LPS injected
WT and Tg26 mice (p=0.60).
LPS exposure increases HIV transcription in spleen but
not in kidney tissue
Since LPS is known to increase expression of NF-kB-regulated
genes, and NF-kB is an important HIV transcription factor, we
studied the effect of LPS on increased HIV transcription in Tg26
mice in vivo. Four to six week old Tg26 mice were injected i.p. with
LPS or saline. 24 hours after injection, renal HIV transcription
levels in LPS-injected mice did not significantly differ from saline-
injected mice (p=0.27).
LPS has been shown to increase splenic HIV transcription in
another HIV-transgenic mouse model [26]. We therefore studied
whether LPS injection increased splenic HIV transcription in
Tg26 mice and whether the change in splenic HIV transcription
differed from kidney. In contrast to kidneys, spleens from LPS-
injected Tg26 mice had a more than 60.1-fold increase in HIV
transcription compared to spleens of saline-injected Tg26 controls
(p,0.028).
Effect of LPS exposure upon HIV transcription in RTEC in
vitro
We then examined the effect of LPS on RTEC HIV tran-
scription in vitro. Since murine cells lack factors necessary to support
optimal HIV transcription[27,28] we studied LPS-induced HIV
transcription in human RTEC. Infection of human RTEC with
wild-type HIVvirusis inefficient[29]. Therefore,inthesestudies we
infected the human RTEC line, RT3, with a VSV-pseudotyped
lentiviral replication-incompetent HIV-1 vector (VSV-NL4-3:DG/
P-EGFP)thathasbeenusedinpreviousstudiesmodelingtheRTEC
response to HIV [19,23,30]. RT3 cells were derived from a patient
biopsy and display normal RTEC morphology and express typical
proximal RTEC markers (Figure 3A and 3B). Three days after
infection, RT3 cells were exposed to 1 mg/ml LPS and HIV RNA
Figure 1. HIV-transgenic mice are not predisposed to LPS-
induced AKI. Blood was drawn from Tg26 mice and wild-type
littermates prior to injection with LPS. (A) Comparison of baseline SUN
demonstrates no statistical difference between the two groups
(P=0.29). (B)Twenty-four hours after LPS injection, similar increases in
SUN were seen in both groups. (C) The rise of SUN in Tg26 and WT mice,
85.4 and 75.1 mg/dL, respectively, was not statistically significant
(P=0.41).
doi:10.1371/journal.pone.0020688.g001
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wild type (WT) mice demonstrated features of acute tubular cell necrosis (ATN) including nuclear condensation (*), cytoplasmic swelling and
hypereosinophilia, and focal loss of nuclei (arrow) only in LPS injected samples (bottom panels, x400) and not in control injected mice (top panels,
x400). Proteinaceous casts (P), a feature of murine HIVAN, were seen in the tubules of both control and LPS injected Tg26 mice. (B) Tubular damage in
LPS injected mice resulted in significantly higher ATN scores compared to control mice (p,.001) but not when compared to each other (p=.60).
doi:10.1371/journal.pone.0020688.g002
Figure 3. LPS induces a minimal increase in HIV transcription in an infected human RTEC cell line. (A) qPCR analysis of RT3 RNA
demonstrated expression of the epithelial markers cytokeratin ande-cadherin and the proximal tubular marker aquaporin-1. RT3 cells did not express
distal tubular marker Tamm-Horsfall protein or von Willebrand’s factor (endothelial marker). (B) The tubular cell line RT3 displays tubular cell
morphology, with polygonal/refractile appearance, and tendency to form characteristic domes when overgrown. (C) The human RT3 cell line was
transduced with a gag/pol-deleted HIV lentiviral vector and incubated with LPS four days later. LPS induced a minimal, but significant (*), increase in
HIV RNA that was 1.32 and 1.47-fold after 24 and 48 hours, respectively (p,0.05).
doi:10.1371/journal.pone.0020688.g003
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inducedaminimal,thoughstatisticallysignificant1.32and1.47-fold
(p,0.05) increase in HIV transcription, respectively (Figure 3C).
Effects of LPS injection on renal cytokine expression HIV
transgenic and wild type mice
Several HIV proteins can alter the ability of cells to respond to
inflammatory stimuli. In particular, the HIV proteins Vpr and Tat
influence the production of immune modulating cytokines and
processing of immunogenic proteins[31,32]. Since production of
proinflammatory mediators by renal parenchymal cells is an
important component of the pathogenesis of AKI, we investigated
whether expression of these factors is different in Tg26 mice
compared to WT mice after LPS or saline injection. Twenty-four
hours after control or LPS injection, total kidney RNA was har-
vested from each mouse and expression of inflammatory mediators
was analyzed via qPCR. There were no significant differences
between saline-injected WT and Tg26 mice for expression of any of
the genes investigated (Table 1). In addition, LPS did not induce
significant changes in expression of TNFa, IFN-a, IFN-b, or IL-10 in
Tg26 or WT mice compared to saline-injected controls (Table 1).
Renal expression ofseveralproinflammatorymediators (CXCL5,IL-
6, ICAM, and MCP-1) was markedly increased by LPS injection in
Tg26 and WT mice (Figure 4). However, there were no significant
differences in the increases in expression of these inflammatory
mediators between LPS-injected Tg26 and WT mice (Table 1).
Discussion
The relationship between AKI and increased mortality has been
clearly established and has not improved appreciably in the past
several decades; a recent study found a 41.1% mortality rate in
hospitalized patients with AKI[33]. HIV-infected patients are
predisposed to AKI both in the hospitalized and ambulatory
settings[1,3]. At present, there are no effective treatments available
for established AKI and the most efficacious strategies for
prevention are minimizing exposure to nephrotoxins and opti-
mizing hemodynamic status in patients at highest risk for AKI[34].
There have been no previous studies using in vivo or in vitro models
to determine the mechanism by which HIV-infection predisposes
patients to AKI. We therefore modeled septic AKI both in vivo and
in vitro to determine whether increased systemic levels of LPS
increase renal HIV transcription and if the presence of HIV within
the kidney is a predisposing factor for more severe AKI, tubular
injury, and altered cytokine induction.
There was no significant difference in renal function or tubular
injury between Tg26 and wild-type mice when measured at
baseline or 24 hours after LPS injection. We chose to perform
these studies in young (one month old) mice, before the Tg26 mice
would develop decreased GFR and histological renal disease.
Since increased age is a risk factor for AKI in humans and there
are no published data on whether pediatric HIV infected patients
are at increased risk of AKI, it is possible that young Tg26 mice
are protected from increased susceptibility to AKI. However,
performing these studies in older mice would be problematic as
Tg26 mice would have significant baseline CKD, which would
likely predispose them to AKI, independent of HIV-specific effects.
The dosage of LPS administered caused detectable changes in
SUN for most, but not all mice. It is possible that this dose may
have obscured an effect that would have been seen at a lower
dosage. However, since LPS does not significantly alter renal HIV
expression or AKI-associated gene expression, we consider it
unlikely that other dosages of LPS would reveal an increased
propensity to AKI in the Tg26 mice.
LPS injection did not induce a significant change in renal HIV
RNA compared to saline injected Tg26 controls. Moreover, we
found that LPS induced a 60-fold increase in splenic HIV RNA
levels. The magnitude of this increase in splenic HIV expression
is similar to that reported by Tanaka et al [26], supporting the
validity of our data obtained using the Tg26 mouse model. Our
findings emphasize in vivo cell specific differences in HIV ex-
pression demonstrated by others in vitro.
Previous studies using Tg26 mice have shown that a low level of
renal HIV expression is correlated with the level of baseline kidney
NF-kB activation. Conversely, in the gut, where baseline NF-kB
activationishigher,HIV transcriptionisincreased[35].ThoughLPS
injection increased expression of several NF-kB regulated genes in
the kidneys of Tg26 mice, this increase in NF-kB activity was not
accompanied by an increase in HIV transcription. It is possible that
LPS injection induced expression of systemic and/or local factors
that suppressed the ability of NF-kB to activate HIV expression.
Though we did not detect upregulation of obvious candidate sup-
pressors of HIV transcription, such as interferon, it is possible that
these mediators may have been upregulated at earlier time points or
that other factors prevented LPS-induced HIV transcription.
Martinka et al. demonstrated persistent NF-kB activation in
podocytes from Tg26 mice.[36] Though podocytes were clearly
present in the Tg26 kidney specimens used in our in vivo studies,
RTEC constitute the great majority of renal cells. Therefore, no
conclusions can be drawn from our data regarding the effect of
Table 1. qPCR analysis of fold change compared to wild type control injected mice.
Tg26 Ctrl
average fold
change
WT LPS
average fold
change
Tg26 LPS
average fold
change
Overall
p-value
p-value for
WT Ctrl vs
Tg26 LPS
p-value for
WT Ctrl vs
WT LPS
p-value for
WT Ctrl vs
Tg26 Ctrl
p-value for
WT LPS vs
Tg26 LPS
CXCL5 0.76 9.60 9.84 .002 .004 .002 .661 .833
ICAM 1.65 7.96 5.08 .009 .016 .009 .380 .347
MCP 1.49 8.49 6.56 .008 .005 .008 .464 .347
TNF 0.83 0.94 0.73 .303
______ ______ ______ ______
IL6 1.16 5.69 4.90 .032 .068 .032 .770 .883
IL10 0.70 2.02 0.92 .869
______ ______ ______ ______
IFN a 0.45 0.60 0.73 .915
______ ______ ______ ______
IFN b 0.63 0.44 0.51 .915
______ ______ ______ ______
doi:10.1371/journal.pone.0020688.t001
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the acute effects of large dosages of LPS on RTEC HIV expression
whereas chronic exposure to lower dosages of LPS may have dif-
ferent effects upon renal function.
Our in vitro studies, were performed to address potential
limitations of the HIV-transgenic model. Specifically, murine cells
may not accurately model HIV transcriptional regulation due to
species-specific factors[27]. For example, Tat, a critical HIV tran-
scription factor, interacts with cyclin T1 (CycT1) at the HIV LTR
to promote HIV transcription[37]. However, murine CycT1 is
unable to facilitate Tat-mediated transcription[27].
To confirm the importance of our data from the Tg26 mice,
we repeated experiments using the human RTEC cell line, RT3.
Since human RTEC undergo apoptosis after chronic HIV infec-
tion in vitro[29], RT3 cells were incubated with LPS four days after
HIV transduction, before HIV-induced cytotoxicity is observed.
The change in HIV transcription in LPS-exposed RT3 cells even
at 48 hours was quite modest and certainly lower than that seen in
mouse spleen. Overall, our in vitro studies suggest that LPS does
not induce a clinically significant increase in RTEC HIV tran-
scription and support our in vivo findings.
LPS-induced cytokine production is a critical determinant of
AKI in murine models of septic AKI[6,38,39]. Because expression
of viral proteins can further alter cytokine production[40–42], we
hypothesized that an exaggerated cytokine response would poten-
tiate the effect of HIV expression in the kidney and worsen the
course of LPS-induced AKI in Tg26 mice. Our analysis included
cytokines, chemokines, and adhesion molecules known to play
important roles in LPS induced kidney injury[6,38,39]. Though
LPS induced marked increases in the expression of several LPS
responsive genes in Tg26 and wild-type mice there were no signi-
ficant differences between Tg26 and wild-type mice in the magnitude
of induction for the inflammatory mediators we examined. While it
is possible that we may have detected differences in expression of
inflammatory mediators if we had studied earlier or later time points,
since there was no difference in severity of renal injury between the
LPS injected groups, it is not likely that such differences would have
been relevant to the pathogenesis of AKI susceptibility.
In clinical studies, the factor that is most closely associated with
increased risk of AKI in HIV-infected patients is the presence of
CKD [1]. In a recent case series, Wyatt et al reported that 84% of
renal autopsy specimens from patients who died with HIV/AIDS
had evidence of histological renal disease, though only one third
had clinical evidence of CKD prior to death. It is possible that the
high prevalence of ‘‘silent’’ CKD in HIV-infected patients is an
important factor that predisposes these patients to AKI.
The Tg26 mice used in these experiments had normal renal
function at the time of injection so the combined effects of sepsis,
HIV infection, and CKD upon AKI susceptibility cannot be
extrapolated from this work. Furthermore, sepsis-related AKI often
occurs in the patients with several risk factors including volume
depletion, hypotension and nephrotoxin exposure. Our model was
not designed to measure the effects of all the factors that may be
encountered in clinical practice and it is possible that another model
of sepsis-induced AKI may produce alternate results.
In conclusion, LPS-induced activation of renal HIV transcrip-
tion does not explain the increased susceptibility of HIV-infected
patients to AKI. This is the first published study examining the
pathomechanisms underlying AKI in the setting of HIV infection.
Additional research is needed to identify the factors responsible for
increased AKI in HIV-infected patients to allow development of
improved strategies for the care of this vulnerable patient population.
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